Adamas Pharmaceuticals Inc. (ADMS) Surged After FDA Approval

Adamas Pharmaceuticals Inc. (ADMS) announced after the bell Thursday that it has received FDA approval for GOCOVRI, for the treatment of dyskinesia in Parkinson's disease patients.

from RTT - Before the Bell http://ift.tt/2gjrcf0
via IFTTT